Temporal trajectory of biofluid markers in Parkinson’s disease
Abstract Full dynamics of biofluid biomarkers have been unknown in patients with Parkinson’s disease (PD). Using data from 396 PD patients and 182 controls in the Parkinson's Progression Markers Initiative (PPMI) database, we estimated long-term temporal trajectories of CSF α-synuclein (α-syn),...
Main Authors: | Min Seok Baek, Myung Jun Lee, Han-Kyeol Kim, Chul Hyoung Lyoo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-94345-8 |
Similar Items
-
Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
by: Yannick Vermeiren, et al.
Published: (2020-07-01) -
Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
by: Seung Ha Lee, et al.
Published: (2017-01-01) -
Biofluid-based Biomarkers for Parkinson's Disease: A New Paradigm
by: Sok Kean Khoo
Published: (2015-11-01) -
Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
by: Chin-Hsien Lin, et al.
Published: (2019-10-01) -
Biofluid-based microRNA Biomarkers for Parkinsons Disease: an Overview and Update
by: Sapana Shinde, et al.
Published: (2015-02-01)